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ABSTRACT
Objectives: We aimed to assess the prevalence of
uterine rupture in Belgium and to evaluate risk factors,
management and outcomes for mother and child.
Design: Nationwide population-based prospective
cohort study.
Setting: Emergency obstetric care. Participation of
97% of maternity units covering 98.6% of the
deliveries in Belgium.
Participants: All women with uterine rupture in
Belgium between January 2012 and December 2013. 8
women were excluded because data collection forms
were not returned.
Results: Data on 90 cases of confirmed uterine rupture
were obtained, of which 73 had a previous Caesarean
section (CS), representing an estimated prevalence of
3.6 (95% CI 2.9 to 4.4) per 10 000 deliveries overall
and of 27 (95% CI 21 to 33) and 0.7 (95% CI 0.4 to
1.2) per 10 000 deliveries in women with and without
previous CS, respectively. Rupture occurred during trial
of labour after caesarean section (TOLAC) in 57 women
(81.4%, 95% CI 68% to 88%), with a high rate of
augmented (38.5%) and induced (29.8%) labour. All
patients who underwent induction of labour had an
unfavourable cervix at start of induction (Bishop Score
≤7 in 100%). Other uterine surgery was reported in the
history of 22 cases (24%, 95% CI 17% to 34%),
including 1 case of myomectomy, 3 cases of
salpingectomy and 2 cases of hysteroscopic resection
of a uterine septum. 14 cases ruptured in the absence
of labour (15.6%, 95% CI 9.5% to 24.7%). No mothers
died; 8 required hysterectomy (8.9%, 95% CI 4.6% to
16.6%). There were 10 perinatal deaths (perinatal
mortality rate 117/1000 births, 95% CI 60 to 203) and
perinatal asphyxia was observed in 29 infants (34.5%,
95% CI 25.2% to 45.1%).
Conclusions: The prevalence of uterine rupture in
Belgium is similar to that in other Western countries.
There is scope for improvement through the
implementation of nationally adopted guidelines on
TOLAC, to prevent use of unsafe procedures, and
thereby reduce avoidable morbidity and mortality.
BACKGROUND
Uterine rupture is a rare, but potentially dev-
astating complication of pregnancy, whereby
the uterine wall tears during pregnancy or
delivery, extending to the uterine serosa and
occasionally involving the bladder or broad
ligament.1 2 The course is usually milder in
case of a uterine dehiscence, when rupture is
conﬁned to the uterine muscle without
affecting the uterine serosa.1 2
Disruption of the uterine wall can be
accompanied by displacement of the baby
into the abdomen, causing severe asphyxia
and perinatal death, and by massive maternal
bleeding necessitating massive transfusion or
hysterectomy to save the mother’s life.
Albeit a rare event, complicating an esti-
mated 0.03% of pregnancies in developed
countries,3 the severity of this complication
has a profound impact on obstetrical
practice.
Large population-based studies in
European countries, including obstetric sur-
veillance systems,4 5 have improved our
knowledge of risk factors and management
of uterine rupture, and have guided strat-
egies for prevention.6–10 In developed coun-
tries, uterine rupture most commonly occurs
in uteri scarred by previous caesarean
section (CS), mainly at term and during
labour, and is even more frequent when
labour is induced or augmented. Awareness
of this risk has contributed to a more
Strengths and limitations of this study
▪ This is a nation-wide study of Belgian mater-
nities, with excellent participation and response
rates (98.8%).
▪ The cases were collected on a monthly basis
using the standard methodology of the Obstetric
Surveillance Systems.
▪ Data from the background population as control
group were limited to those available in the
Belgian perinatal registry.
▪ The study lacks a reliable control for
under-reporting.
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cautious policy towards trial of labour after caesarean
section (TOLAC), stated in widely used guidelines.1 11 12
Belgium has a large number of tertiary referral
centres providing neonatal intensive care (n=19) along
with a high concentration of small-volume maternity
units.13 Obstetric care is mainly organised in private
practice. The impact of this almost exclusively
specialist-led care, the high rate of induction of labour13
(26.5% in 2013)14–16 and the steadily increasing CS rate
(20.7% in 201314–16) on the prevalence of uterine
rupture in Belgium is currently not known.
We aimed to investigate the prevalence of uterine
rupture in Belgium and to assess risk factors, manage-
ment and outcomes, for mother and child.
METHODS
Belgian Obstetric Surveillance System (B.OSS)
Uterine rupture in Belgium has been registered as part
of a national reporting system to study rare obstetric
complications, being the ﬁrst completed study of this
newly developed project. The B.OSS was constituted in
2011 and initiated registration in January 2012, with
support of the College for Mother and Newborn, a con-
sultative body of the Federal Public Service of Health in
Belgium.
Case reporting
B.OSS has adopted the methodology for case reporting
of severe obstetric morbidity developed by the UK
Obstetric Surveillance System (UKOSS),4 pioneer of the
obstetric surveillance systems united in the International
Network of Obstetric Survey Systems (INOSS).5
Participation of 97% of Belgian maternity units (n=113)
was obtained, covering 98.6% (248 681) of deliveries in
the study period. Brieﬂy, an appointed contact person
(obstetrician (OB)/gynaecologist or senior-midwife) in
each participating maternity unit (n=110) was invited by
monthly mailing to report a selected number of rare
obstetric complications (including uterine rupture, as
well as eclampsia and peripartum hysterectomy, and/
or embolisation for massive obstetric haemorrhage)
that had occurred in the preceding month. In the
event a case was reported in reply, the contact person
was asked to complete an extensive data collection
form. Conﬁdentiality was guaranteed for mother, pro-
vider and hospital; person-identiﬁable information was
eliminated from data-analysis. In case of incomplete
reporting, the appointed contact person was encour-
aged repeatedly by email and phone to provide
missing data, up to 6 months following the period of
case reporting.
Data collection, processing and cleaning
Initially, data on reported cases were obtained through
use of a standardised form, ﬁlled out electronically or
on hard copy, according to preference. Web-based data-
collection was gradually introduced following the launch
of the B.OSS website (http://www.b-oss.be) in August
2013, facilitating monthly reporting and completion of
data collection forms online. Standardised forms were
entered manually into the website forms by two investi-
gators, independently, to assure quality of data entry.
Collected data of completed online data collection
forms were coded and exported as a comma-separated
values ﬁle.
Registered variables
Data collection forms requested information on mater-
nal characteristics, medical history and obstetrical
history, details on the index pregnancy, circumstances of
the event, and the management and outcome for
mother and neonate.
Case definition
B.OSS aimed to collect all cases of uterine rupture in
Belgium at any gestational age corresponding to an ana-
tomical deﬁnition (delineated by UKOSS7) or to a clin-
ical deﬁnition (delineated by the LEMMoN study in the
Netherlands8), allowing for the comparison of Belgian
data with both population-based studies. Uterine
rupture as deﬁned by UKOSS is ‘a complete separation
of the wall of the pregnant uterus, with or without
expulsion of the fetus, involving rupture of the mem-
branes at the site of the uterine rupture or extension
into uterine muscle separate from any previous scar,
and endangering the life of the mother or the fetus’.
Uterine rupture as deﬁned by the LEMMoN study is
‘the occurrence of clinical symptoms leading to an
emergency CS, at which the presumed diagnosis of
uterine rupture was conﬁrmed; or a peripartum hyster-
ectomy or laparotomy is required for uterine rupture
after a vaginal birth’.
Anatomical details were requested in the data collec-
tion forms, deﬁning the status of the myometrium, the
peritoneum and the fetal membranes. This anatomical
distinction enables the identiﬁcation of cases that corres-
pond to the UKOSS deﬁnition and the comparison with
other population-based studies that have used anatom-
ical deﬁnitions in the same manner. B.OSS has speciﬁc-
ally excluded cases of asymptomatic dehiscence (intact
uterine peritoneum) noted incidentally at CS, in accord-
ance with UKOSS7 and LEMMoN.8
Study period
B.OSS aimed to collect all cases of uterine rupture
occurring in Belgium from January 2012 to December
2013.
Missing data
Eight reported cases were excluded from the present
analysis, because data collection forms were not
returned. Data collection forms that were returned were
not always complete for all variables. Study data were
evaluated by the number of cases missing per variable
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and by the number of variables missing per case. No
further cases were excluded because of missing data.
Statistical analysis
The most recently available data from the Belgian peri-
natal registry were used as denominator or control
group to calculate rates of prevalence and relative risks.
The Belgian perinatal registry (Studiecentrum voor
Perinatale Epidemiologie (SPE) in Flanders,14 Centre
d’Epidémiologie Périnatale (CEpiP) in Brussels15 and
Wallonia16) collects data on a mandatory basis, covering
nearly 100% of births in Belgian maternity units and
homebirths. A selected set of perinatal data are recorded
by the OB, midwife and neonatologist immediately after
a birth. According to Belgian legislation, births are regis-
tered as such, in case of a live birth or stillbirth at or
after 22 completed weeks of gestation or, if gestational
age is missing, at a birth weight of 500 g or more.
The overall prevalence of uterine rupture was calcu-
lated using the total number of mothers who had
given birth in Belgium in 2012–2013, as denominator,
corrected for three hospitals that did not participate
in B.OSS. The number of mothers with previous CS,
in 2012–2013, was used as denominator to calculate
the prevalence of uterine rupture in women with and
without previous CS. Belgium has a high rate of induc-
tion of labour, but data of method or medication used
for induction are not available. Sociodemographic
and obstetric risk factors were obtained from SPE14
and CEpiP (2012–2013)15 16; data on marital status
and employment were only available from CEpiP.
Neonatal asphyxia was deﬁned as Apgar score <7 at
5 min and/or the umbilical artery pH≤7.0, and/or need
for resuscitation including endotracheal ventilation,
and/or neurological manifestations (seizures), and/or
whole body hypothermia treatment initiated after
birth.17 Relative risks and 95% CIs were calculated in
univariate analyses, comparing frequencies of events
between the study group and control group, with ordin-
ary Pearson’s χ2 tests using weighted cases when appro-
priate. p Values of <0.05 were considered statistically
signiﬁcant. Data were analysed using the statistical soft-
ware package IBM SPSS statistics V.22.0 (IBM Corp, IBM
SPSS Statistics for Windows, Version 22.0, Armonk,
New York, USA: IBM Corp, 2013).
RESULTS
Prevalence
From January 2012 to December 2013, 90 conﬁrmed
cases of uterine rupture were documented. Eight more
reported cases needed to be excluded because of
lacking data collection forms. The corresponding preva-
lence of uterine rupture in Belgium is therefore esti-
mated at 3.6 (95% CI 2.9 to 4.4) per 10 000 deliveries.
When taking into account only cases of complete
rupture (n=74), the estimated prevalence is 2.9 (2.3 to
3.7). Details on reported cases and completeness of data
collection forms are shown in ﬁgure 1.
Risk factors
Women’s characteristics
Relevant sociodemographic, medical and obstetrical
characteristics are displayed in table 1, in comparison
with national data when available. Of note, patients with
uterine rupture included six cases (7.7%) with docu-
mented uterine anomaly, of whom two had a septal
resection prior to the index pregnancy, and one case of
uterine rupture in a patient with osteogenesis imper-
fecta type 1. Rupture in the latter patient, who had
undergone a previous CS, occurred during the latent
phase of labour at term (38 weeks) and involved a longi-
tudinal tear towards the fundus.
Obstetrical risk factors
Previous CS and miscellaneous uterine surgery
Seventy-three cases of uterine rupture (81.1%) occurred
in women who had at least one previous CS, represent-
ing an estimated prevalence of 27 (95% CI 21 to 33) per
10 000 deliveries in women with previous CS. Seventeen
cases of uterine rupture (18.8%) were observed in
women who did not have a previous CS, representing an
estimated prevalence of 0.7 (95% CI 0.4 to 1.2) per
10 000 deliveries in women without previous CS. Eight
Figure 1 Flowchart of case reporting and data collection.
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women without a previous CS (8/17) had one or more
other types of uterine surgery documented in their
history (dilation and curettage (D&C) (n=5), salpingec-
tomy (n=2), resection of uterine septum (n=2), myo-
mectomy (n=1), manual removal of the placenta (n=1)).
In none of these cases was uterine perforation con-
ﬁrmed. Similarly, 14 women with previous CS also had a
history of another type of uterine surgery (D&C (n=12),
manual removal of placenta (n=1), salpingectomy for an
interstitial pregnancy (n=1)); with documented uterine
perforation in the latter case followed by suturing of the
uterine cornua. Interestingly, this rupture occurred at
the site of the cornual scar. Finally, nine women did not
have any surgical risk factor that could explain a weak-
ness in the uterine wall (see online supplementary
ﬁgure S1).
In the cases with previous CS, the interpregnancy
interval was beyond 24 months in 58% of the cases, 12–
23 months in 24% of cases and <12 months in 12 cases
(18%), of whom four became pregnant within the ﬁrst
6 months after previous CS.
Labour and use of uterotonic drugs
Four cases of uterine rupture occurred before 24 com-
pleted weeks of gestation. In one patient, uterine
rupture occurred during termination of pregnancy at
18 weeks, by means of prostaglandins, in a patient with
two previous CS. The second patient received prosta-
glandins because of intrauterine fetal death (IUFD) at
an estimated 22 weeks in an unrecognised pregnancy;
this patient had undergone four previous CS. The third
case was a rupture at 18 weeks in a previously unrevealed
bicornuate uterus. The fourth case was a fundal rupture
at 18 weeks at the site of a placenta percreta. This
patient had two previous CS and two D&C’s for termin-
ation of pregnancy and was managed by a hysterectomy.
These four cases were excluded from analysis of neo-
natal outcome.
Table 1 Relevant sociodemographic, medical and obstetrical risk factors in cases of uterine rupture
Cases of uterine rupture
2012–2013 (n=90)*
n, %
Background
population
2012–2013
(n=252 272)
n, %
Unadjusted RR
(95% CI) p Value
Sociodemographic factors
Maternal age ≥35 years 17 (18.8) 43 256 (17) 1.11 (0.72 to 1.70) 0.6
BMI at booking ≥30 kg/m2 13 (19.6) 29 453 (12) 1.59 (0.9 to 2.59) 0.05
Ethnicity non-white † 5 (5.5) – – –
Neither married nor cohabiting 3 (3.8) 20 785 (17) 0.22 (0.07 to 0.69) 0.008
Unemployed 22 (24.4) 51 296 (43) 0.72 (0.50 to 1.02) 0.06
Smoking 8 (8.8) – – –
Medical factors
Uterine anomaly (bicornuate,
septate)
6 (6.6) – – –
Connective tissue disease‡ 1 (1.1) – – –
Obstetrical factors
Parity ≥3 9 (10) 18 855 (7.4) 1.33 (0.71 to 2.48) 0.3
Nulliparity 6 (6.6) 110 711 (43.9) 0.15 (0.07 to 0.32) <0.0001
Induction of labour 24 (27.9) 68 703 (26.7) 1.03 (0.7 to 1.4) 0.8
Previous CS 73 (81.1) 27 007 (10.7) 7.57 (6.85 to 8.37) <0.0001
Previous CS, cases <24 weeks
excluded
70 (81.3)
Trial of labour after CS 57/70 (81.4) 12 754/27 007 (47.2) 1.39 (1.15 to 1.69) <0.001
Interpregnancy interval
≤12 months
12 (16.4) – – –
Artificial reproductive technology
(IVF/ICSI)
4 (4.4) 9233 (3.7) 1.21 (0.46 to 3.15) 0.6
Abnormal placentation (accreta,
increta, percreta)
1 (1.1) – – –
Birth weight ≥4000 g 11 (12.2) 19 967 (7.8) 1.67 (0.96 to 2.90) 0.06
Breech presentation 4 (4.4) 12 630 (4.9) 0.93 (0.35 to 2.42) 0.8
*Study data were not complete for all variables; data available on BMI (n=66), marital status (n=77), employment (n=71), smoking (n=87),
ART (n=89), birth weight (n=84), interpregnancy interval (n=67).
†White ethnicity defined as European, Middle-Eastern, North-African, white South-African. Five women were of African descent defined as
African, Caribbean or Afro-American ethnicity.
‡Connective tissue disease: the study included one known case of osteogenesis imperfecta type I.
ART, artificial reproductive technology; BMI, body mass index; CS, Caesarean section; CTG, cardiotocography; ICSI, intracytoplasmic sperm
injection; IVF, in vitro fertilisation; RR, relative risk.
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The median gestational age of the 86 remaining cases
was 39 weeks (range 25–41 weeks).
In 71 cases (82.5%), uterine rupture occurred during
labour. Of these, labour was induced in 22 cases
(25.5%) and augmented by use of oxytocin in 24 cases
(28%) while another 24 cases laboured spontaneously
without the use of uterotonic drugs (28%). Sixteen cases
were stated to have ruptured in the absence of labour
(18.6%), two of these women having received vaginal
prostaglandins in an attempt to induce labour (see
online supplementary ﬁgure S2).
The rate of TOLAC in this study was 81.4% (n=57),
including in 17 women where it was induced (29.8%)
and in 22 where it was augmented (38.5%). The Bishop
score prior to induction, as the most commonly used
predictor for the readiness of the cervix for induction,18
was unfavourable in the majority of these women (<6 in
82%, ≤7 in 100%).
Presentation of the uterine rupture
Signs and symptoms that raised suspicion of uterine
rupture are demonstrated in table 2. In ﬁve cases, there
were signs of maternal shock (hypotension, sweating,
pallor, maternal collapse); shoulder pain was mentioned
in one case.
In 19 cases (21.1%), the diagnosis was made after
vaginal delivery, with vaginal bleeding occurring as the
presenting sign in 47% of the cases. Delivery was assisted
with vacuum (n=10) or forceps (n=2) because of fetal
distress (n=7) or maternal reasons (n=5). One case of
uterine rupture was detected during routine manual
examination of the uterus postdelivery, an obsolete pro-
cedure that is still practised by a minority of OBs.
Management of uterine rupture and outcome of mother and
child
Emergency CS was performed in 67 women (74%).
Dilation at the moment of decision was 0–3 cm in nearly
half of these women (n=32), while nine women (13%)
were fully dilated.
Eight women underwent a hysterectomy (9%) (see
online supplementary ﬁgure S3). Reported reason to
perform the hysterectomy was massive haemorrhage in
four cases while the other four cases underwent hyster-
ectomy mainly because of major anatomical damage to
the uterus.
Location of the uterine rupture was in the lower
uterine segment in the majority of cases (n=57, 63%).
Other reported locations of rupture were fundal (n=13,
14%), longitudinal (n=12, 13%), high transverse (n=4,
4%) and cornual (n=2, 2%). The bladder or the para-
metrium was involved in 7 (8%) and in 12 women
(13%), respectively.
Twenty women (22.2%) were admitted to an intensive
care unit (ICU), with a mean stay of 2.1 (1–7) days.
Three women required intubation and ventilation, one
patient suffered from aspiration pneumonia. Thirty-six
women received transfusion (40%), 14 women were
transfused with >4 units of packed cells (PC) and fresh
frozen plasma (FFP). Other reported maternal morbid-
ity included a vesicovaginal ﬁstula (n=1), a nephrostomy
(n=1) and an abcedation (n=1).
The neonatal outcome is demonstrated in the ﬂow-
chart in ﬁgure 2. There were 10 perinatal deaths in con-
sequence of the uterine rupture: two neonates died
during rupture before birth and eight neonates died in
the ﬁrst 7 days of life. Early neonatal deaths occurred at
Table 2 Signs and symptoms, and combinations of symptoms prior to diagnosis of uterine rupture
Presence of
symptom
N (%)
Combination of two symptoms
Abdominal
pain
Vaginal
bleeding Hypertonia
Acute absence of
contractions Haematuria
Abnormal CTG 55/74 (74.3) 36/74 (48.6) 16/74 (21.6) 9/73 (12.3) 6/74 (8.1) 4/74 (5.4)
Abdominal pain 59/89 (66.2) 16/87 (18.3) 8/86 (9.3) 5/87 (5.7) 5/87 (5.7)
Vaginal bleeding 27/86 (31.3) 1/86 (1.1) 3/86 (3.4) 1/86 (1.1)
Hypertonia 9/85 (10.5) 2/85 (2.3) 1/85 (1.1)
Acute absence of
contractions
8/86 (9.3) 3/86 (3.4)
Haematuria 6/86 (6.9)
Figure 2 Neonatal outcome in 90 cases of uterine rupture.
Cong, congenital; IUFD, intrauterine fetal death.
Vandenberghe G, et al. BMJ Open 2016;6:e010415. doi:10.1136/bmjopen-2015-010415 5
Open Access
a term gestational age (>39+0 weeks),19 with the excep-
tion of one at extreme preterm (25 weeks) and two at
moderate preterm (34 weeks) gestational age. Perinatal
mortality observed with uterine rupture occurred at a
rate of 117/1000 (95% CI 60 to 203) compared with the
perinatal mortality rate of 6.7/1000 in the background
population (RR 17.3, 95% CI 9.6 to 31.0).
Seventy-four neonates survived (86%), of whom 29 suf-
fered from asphyxia (39%). Twenty-four neonates
needed intubation and ventilation (33%), two neonates
needed resuscitation at birth, ﬁve received cooling
therapy (7%) and one neonate required anticonvulsant
drugs. Median gestational age at birth was 39 weeks
(range 29–41 weeks) in the group of surviving neonates.
A higher risk of severe maternal outcome (hysterec-
tomy, transfusion >4 units of PC, admission to ICU) and
severe neonatal outcome (asphyxia, intrapartum or neo-
natal death) was observed in women without previous
CS than in women with a previous CS. A more in-depth
analysis taking history of other uterine surgery into
account reveals a further increased risk of severe mater-
nal outcome in those women with other uterine surgery;
however, numbers in this study are too small to permit
ﬁrm conclusions (see online supplementary table S1).
DISCUSSION
The estimated prevalence (3.6/10 000 deliveries) of
uterine rupture in Belgium, based on this study, is
similar to that found in other Western countries.
Compared with three national population-based studies
that have used a similar approach: the Netherlands
(LEMMoN-study),8 the UK (UKOSS)7 and the Nordic
countries (Nordic Obstetric Surveillance Study,
NOSS),10 this prevalence stands roughly midway
between the low rate of UKOSS (1.9/10 000) and the
higher rates of NOSS (5.5/10 000) and LEMMoN (5.9/
10 000). Important is that UKOSS and NOSS have
included only cases of complete rupture, while
LEMMoN has no information on the anatomical details
of the ruptures. The estimated prevalence of complete
uterine ruptures in Belgium is 2.9/10 000 deliveries.
The strengths of this study are its methodology—col-
lecting cases prospectively on a monthly basis—and its
national design with excellent participation and
response rates (98.9%) from the Belgian maternity
units. The small number of cases, intrinsic to rare but
severe obstetric complications, warrants caution,
however, in making strong inferences. Furthermore, we
were unable to control for several variables not available
from the background population through the Belgian
perinatal registry. Finally, due to the study design and
non-mandatory reporting of severe pregnancy complica-
tions, under-reporting may have biased our results to
some extent, an issue we will address in a forthcoming
study.
The majority of cases in this study ﬁt the pattern of
known risk factors for uterine rupture: scarring by a
previous CS, being beyond 37 weeks of gestation, being
in labour and being induced or augmented. Still, 17
cases had no previous CS, of which 8 ruptured before
37 weeks, and of which 2 were not in labour. Insight into
circumstances and risk factors of rare cases of uterine
rupture, namely occurring in the unscarred and/or
preterm, and/or non-labouring uterus, can be improved
by the study of a larger number of cases; the INOSS col-
laborative5 may be the only route to achieve adequate
numbers of these rare cases of uterine rupture.
This study conﬁrms a higher risk of severe maternal
and neonatal outcome when a rupture occurs in a
uterus without previous CS, than among women with
previous CS, as reported previously by the LEMMoN
study,8 among others.3 20 This can be explained by the
delay in diagnosis because of a lower suspicion of
uterine rupture in an unscarred uterus and by the
higher risk of massive haemorrhage in the more vascu-
lar, unscarred myometrium compared with in uterine
scar tissue. A further increased risk of severe maternal
outcome was observed when accounting for a history of
other uterine surgery, though our observations are
hypothesis-generating and need conﬁrmation in larger
study sets.
Evidence on the risk of uterine rupture following
transabdominal or laparoscopic myomectomy remains
inconclusive, because surgeons recommend a primary
CS in a high number of these women. Based on the lit-
erature review, the risk of uterine rupture following myo-
mectomy appears to be comparable to the risk after
previous low transverse CS (around 0.5–0.7%).21
Evidence-based guidelines on the mode of delivery fol-
lowing myomectomy, however, are not available.1
Further, this study includes three cases of fundal uterine
rupture following salpingectomy, and two cases following
hysteroscopic resection of a uterine septum. Evidence of
uterine rupture following salpingectomy22 23 or follow-
ing resection of a uterine septum24 is even more scarce,
limited to case reports and series. In line with myomect-
omy, surgeons should evaluate and document the risk of
uterine rupture based on intraoperative ﬁndings; next,
OBs should be aware of this potential risk during ante-
natal care. Finally, to what extent can we assign the
occurrence of a uterine rupture to an unnoted perfor-
ation during routine surgical procedures such as D&C
(n=17 in this study), diagnostic or simple operative hys-
teroscopy, or even the insertion of an intrauterine
device? The exceptional case reports in the literature, in
view of the frequency of these procedures, suggest that
these are merely accidental ﬁndings.25 26 Information
on the prevalence of these routine surgical procedures
in the background pregnant population, in relation to
the prevalence of these procedures in a uterine
rupture cohort, could provide a more accurate estima-
tion of the relative risk. Linkage between national
birth and medical registers, as is the case in the
Nordic countries,27 may allow for studies of such
magnitude.
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The overall CS rate in Belgium is slowly increasing
and has just exceeded the landmark of 20%. Although
this rate is still acceptable13 the trend causes concern,
awakened by recent reporting of the WHO stating that
CS rates higher than 10% are not associated with reduc-
tions in maternal and newborn mortality rates.28
Belgium has no national guidelines for TOLAC speciﬁc-
ally, hence Belgian OBs will turn to various guidelines
(Royal College of Obstetricians and Gynaecologists
(RCOG),1 American College of Obstetricians and
Gynecologists (ACOG),11 Nederlandse Vereniging voor
Obstetrie & Gynaecologie (NVOG),29 French College of
Gynecologists and Obstetricians (CNGOF)30) and litera-
ture to rely on in their daily practice. We observe a
restrictive policy towards TOLAC in Belgium: in 2012–
2013, 47.2% of Belgian women with previous CS
attempted a vaginal birth in their next pregnancy, with
success in 69%.14–16 The estimated TOLAC rate in the
Netherlands and the UK was 71.7% and 52.2%, success-
ful in 76% and 63.4%, respectively.31 32
The percentage of women with TOLAC that was
induced or augmented in this study is similar to that
reported in the LEMMoN study (28% induced, 25% aug-
mented),8 yet higher than observed in the UKOSS study
(14% induced, 25% augmented).7 Prostaglandins were
used in 27% (compared with 13% and 14% in LEMMoN
and UKOSS, respectively). The reported doses and regi-
mens were not according to guidelines in a small number
of cases (intervals <3 h, maximum 24 h dose exceeded,
misoprostol for induction of labour at 38 weeks). Thus,
ﬁve cases of TOLAC were noted to be induced at 38–
39 weeks in the absence of a medical indication. These
ﬁndings suggest that, despite an overall cautious attitude
towards TOLAC in Belgium, a number of uterine rupture
cases may have been avoidable as they were preceded by
unneeded and unsafe procedures, inconsistent with
current widely accepted guidelines.1 11 12 30 33
Accordingly, there seems to be scope for improvement
in promoting a more liberal policy towards TOLAC in
appropriate candidates in Belgium aiming to reduce the
repeat and thus overall CS rate. Whether this will effect-
ively result in a signiﬁcant reduction of associated mor-
bidity (rate of abnormally invasive placenta, massive
obstetric haemorrhage, uterine rupture), may be the
subject of future B.OSS surveillance.
CONCLUSION
On the basis of the ﬁndings in this study, we consider
the need for nationally adopted guidelines on TOLAC
in Belgium. These should be developed to improve the
awareness of true uterine rupture risk, and thereby
prevent unsafe procedures on the one hand, and
promote safe TOLAC in appropriate candidates on the
other, to enable reduction of the repeat and overall CS
rate. There is need for further research on the true risk
of uterine rupture following myomectomy and other
uterine surgical procedures that similarly injure the
myometrium, to develop evidence-based guidelines on
the delivery mode in subsequent pregnancies. The
INOSS enables the study of rare cases of uterine
rupture, namely in the unscarred and/or preterm, and/
or non-labouring uterus and recurrent uterine rupture.
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